AlphaCore Capital’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $44.8K | Buy |
540
+532
| +6,650% | +$44.1K | ﹤0.01% | 786 |
|
|
2025
Q1 | $675 | Buy |
+8
| New | +$675 | ﹤0.01% | 724 |
|
|
2024
Q1 | – | Sell |
-1,429
| Closed | -$128K | – | 379 |
|
|
2023
Q4 | $128K | Buy |
+1,429
| New | +$128K | 0.02% | 234 |
|
|
2023
Q3 | – | Sell |
-100
| Closed | -$8.32K | – | 383 |
|
|
2023
Q2 | $8.32K | Hold |
100
| – | – | ﹤0.01% | 305 |
|
|
2023
Q1 | $7.62K | Buy |
+100
| New | +$7.62K | ﹤0.01% | 205 |
|
|
2021
Q4 | – | Sell |
-200
| Closed | -$25K | – | 135 |
|
|
2021
Q3 | $25K | Buy |
+200
| New | +$25K | 0.01% | 93 |
|